MegaRobo raises nearly $200M in round backed by Oman Investment Authority
According to AI Funding Tracker, which cited Bloomberg, MegaRobo Technologies has closed a round of nearly $200 million that includes Oman Investment Authority, the Omani sovereign wealth fund. The company's release carried a Suzhou dateline, while DealStreetAsia describes it as Beijing-headquartered, so the base city is reported inconsistently. The money is earmarked for core technology, overseas growth of its AI for Science unit, and infrastructure that lets AI operate in complex physical settings.
CMB International is the other new investor. Asia Investment Capital, Granite Asia and Sinovation Ventures, all earlier backers, also put in more capital. Neither the round type nor the valuation has been disclosed. Reporting also differs on leadership: Dealroom describes Oman as the lead, while MLQ notes the company did not name a lead investor. Total funding is about $600 million, including a near $300 million Series C in June 2022 that Goldman Sachs Alternatives, Asia Investment Capital and Granite Asia co-led and that pushed valuation above $1 billion.
MegaRobo was founded in 2016 and builds robotic systems and software that let AI models run physical lab experiments, mostly for drug research. Its Megalaxy Lab platform lets scientists and AI agents send tests to robotic labs and has served more than 200 of them. The company says it has more than 500 customers overall, mostly drug makers, biotech firms and research labs. About 80% of revenue comes from China. MegaRobo filed for a Hong Kong listing in mid-2025 and remains in the IPO queue.
Why it matters
For companies selling AI into science, the deal shows that investors will fund the hardware layer that closes the loop between a model's prediction and a physical test. Models can propose compounds or protocols, but someone has to run the experiment and feed results back. Builders who own that link may hold more leverage than pure software rivals.
Founders should note who the buyers are. Pharma companies and academic labs purchase this equipment, so instrument integration, data capture and fit with existing lab systems can matter as much as model quality. Investors should weigh concentration risk: about 80% of revenue comes from one country, and Dealroom notes that the custom-project model carries thin margins and heavy cash burn.
Key points
- 1Cumulative funding now stands at about $600 million since the company was founded in 2016.
- 2The company has not disclosed the round type, the valuation, or a lead investor.
- 3CMB International is a first-time investor, joining Oman Investment Authority in this round.
- 4The 2022 Series C of nearly $300 million was co-led by Goldman Sachs Alternatives, Asia Investment Capital and Granite Asia.
- 5About 80% of MegaRobo's revenue comes from China, and its Hong Kong IPO application from mid-2025 remains pending.